Association between the CYP1A1 T3801C polymorphism and risk of cancer: Evidence from 268 case-control studies

Gene

Volumn 534, Issue 2, 2014, Pages 324-344

  He, Xiao Feng ^a   Wei, Wu ^a   Liu, Zhi Zhong ^b   Shen, Xu Liang ^a   Yang, Xian Bin ^a   Wang, Su Lan ^a   Xie, Dao Lin ^a  

^a CHANGZHI MEDICAL COLLEGE   (China)

^b ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

Author keywords

Cancer; CYP1A1; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

CYTOCHROME P450 1A1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GALLBLADDER CANCER; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HEAD AND NECK CANCER; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LARYNX CANCER; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; META ANALYSIS (TOPIC); MOUTH CANCER; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; THYROID CANCER; UTERINE CERVIX CANCER;

CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 84890428864     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.10.025     Document Type: Article

References (298)

1. C. Acevedo Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people Prostate 57 2003 111 117
2. M. Adonis V. Martínez P. Marín D. Berrios L. Gil Smoking habit and genetic factors associated with lung cancer in a population highly exposed to arsenic Toxicol. Lett. 159 2005 32 37
3. M. Adonis V. Martínez P. Marín L. Gil CYP1A1 and GSTM1 genetic polymorphisms in lung cancer populations exposed to arsenic in drinking water Xenobiotica 35 2005 519 530
4. A. Agudo Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition Cancer Epidemiol. Biomarkers Prev. 15 2006 2427 2434
5. F. Al-Dayel Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population Leuk. Lymphoma 49 2008 122 129
6. A.K. Alexandrie M.I. Sundberg J. Seidegård G. Tornling A. Rannug Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types Carcinogenesis 15 1994 1785 1790
7. D. Anantharaman P.M. Chaubal S. Kannan R.A. Bhisey M.B. Mahimkar Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator Carcinogenesis 28 2007 1455 1462
8. V.P. Androutsopoulos A.M. Tsatsakis D.A. Spandidos Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention BMC Cancer 9 2009 187
9. J. Ashley-Martin J. VanLeeuwen A. Cribb P. Andreou J.R. Guernsey Breast cancer risk, fungicide exposure and CYP1A1*2A gene–environment interactions in a province-wide case–control study in Prince Edward Island, Canada Int. J. Environ. Res. Public Health 9 2012 1846 1858
10. K.A. Ashton Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk Cancer Epidemiol. 34 2010 328 337
11. M. Aydin-Sayitoglu O. Hatirnaz N. Erensoy U. Ozbek Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias Am. J. Hematol. 81 2006 162 170
12. L.R. Bailey Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans Cancer Res. 58 1998 65 70
13. G. Balta Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia Am. J. Hematol. 73 2003 154 160
14. C.B. Begg M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
15. E.V. Belogubova Allelic distribution of the CYP1A1 in lung cancer patients, middle-aged tissue donors and in elderly people without cancer Vopr. Onkol. 50 2004 165 168
16. E.V. Belogubova Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects J. Cancer Res. Clin. Oncol. 132 2006 327 331
17. S. Boccia CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer J. Cancer Res. Clin. Oncol. 134 2008 93 100
18. P. Bolufer Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia Br. J. Haematol. 136 2007 590 596
19. P. Bolufer The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia Haematologica 92 2007 308 314
20. A. Bonaventure Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE) Cancer Causes Control 23 2012 329 345
21. C. Bouchardy CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population Biomarkers 2 1997 131 134
22. S.M. Boyapati Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case–control study of Chinese women Cancer 103 2005 2228 2235
23. J. Brockmöller I. Cascorbi R. Kerb I. Roots Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk Cancer Res. 56 1996 3915 3925
24. N.E. Bufalo Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants Endocr. Relat. Cancer 13 2006 1185 1193
25. W.J. Butler P. Ryan I.C. Roberts-Thomson Metabolic genotypes and risk for colorectal cancer J. Gastroenterol. Hepatol. 16 2001 631 635
26. D.D. Cáceres Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions Eur. J. Epidemiol. 20 2005 79 88
27. R. Canalle R.V. Burim L.G. Tone C.S. Takahashi Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia Environ. Mol. Mutagen. 43 2004 100 109
28. A.G. Casson Associations between genetic polymorphisms of phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma Cancer Detect. Prev. 27 2003 139 146
29. I.H. Cha Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer Yonsei Med. J. 48 2007 233 239
30. P. Chacko T. Joseph B.S. Mathew B. Rajan M.R. Pillai Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome Mutat. Res. 581 2005 153 163
31. B.L. Chang Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk Int. J. Cancer 106 2003 375 378
32. F. Chang T. Hu G. Wang Relationship between CYP1A1 and GSTM1 genetic polymorphisms and lung cancer susceptibility in population of Inner Mongolia Zhongguo Fei Ai Za Zhi 9 2006 413 417
33. T.W. Chang Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan Breast 15 2006 754 761
34. S. Chatterjee Prevalence of CYP1A1 and GST polymorphisms in the population of northeastern India and susceptibility of oral cancer Oncol. Res. 17 2009 397 403
35. K. Chen A case–control study on the association between genetic polymorphisms of metabolic enzymes and the risk of colorectal cancer Zhonghua Liu Xing Bing Xue Za Zhi 26 2005 659 664
36. H.C. Chen Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility Eur. J. Cancer Prev. 17 2008 251 258
37. J. Chen M. Cheng L. Yi C.B. Jiang Relationship between CYP1A1 genetic polymorphisms and renal cancer in China Asian Pac. J. Cancer Prev. 12 2011 2163 2166
38. C.M. Chen Effects of CYP1A1 and GSTM1 gene polymorphisms and BPDE-DNA adducts on lung cancer Zhonghua Yi Xue Yi Chuan Xue Za Zhi 29 2012 23 27
39. Y.J. Cheng No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan Cancer Epidemiol. Biomarkers Prev. 12 2003 179 180
40. C.J. Chung The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype Toxicol. Appl. Pharmacol. 266 2013 254 259
41. J. Clavel Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy Eur. J. Cancer Prev. 14 2005 531 540
42. S.P. Cleary M. Cotterchio E. Shi S. Gallinger P. Harper Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk Am. J. Epidemiol. 172 2010 1000 1014
43. K. Cordero Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals Oncol. Lett. 1 2010 549 553
44. M.L. Cote Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study Lung Cancer 55 2007 255 262
45. M.L. Cote Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women Carcinogenesis 30 2009 626 635
46. F. Crofts A novel CYP1A1 gene polymorphism in African-Americans Carcinogenesis 14 1993 1729 1731
47. N.M. Cury Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk Mol. Biol. Rep. 39 2012 1055 1063
48. L. da Fonte de Amorim CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women Cancer Lett. 181 2002 179 186
49. F. D'Alò Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia Haematologica 89 2004 664 670
50. M. Darazy CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese Genet. Test. Mol. Biomarkers 15 2011 423 429
51. S.G. Davey M. Egger Meta-analyses of randomized controlled trials Lancet 350 1997 1182
52. A.J. De Roos Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors Neuro. Oncol. 8 2006 145 155
53. A. Demir The role of CYP1A1 Msp1 gene polymorphisms on lung cancer development in Turkey Tuberk. Toraks 53 2005 5 9
54. R. DerSimonian N. Laird Meta-analysis in clinical trials Control. Clin. Trials 7 1986 177 188
55. I.A. Dialyna D.A. Arvanitis D.A. Spandidos Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer Int. J. Mol. Med. 8 2001 79 87
56. I.A. Dialyna S. Miyakis N. Georgatou D.A. Spandidos Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk Oncol. Rep. 10 6 2003 1829 1835
57. B. Diergaarde Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer Cancer Epidemiol. Biomarkers Prev. 17 2008 1751 1759
58. G. Ding CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis Mol. Biol. Rep. 40 2013 3483 3491
59. J.A. Doherty Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer Cancer Epidemiol. Biomarkers Prev. 14 2005 357 366
60. V. Dolzan Z. Rudolf K. Breskvar Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients Pflugers Arch. 439 2000 R29 R30
61. C. Dong Q. Yang B. Jiang Q. Dong Study on the relationship between polymorphisms of CYP1A1 gene and susceptibility of lung cancer in Sichuan population Zhongguo Fei Ai Za Zhi 7 2004 38 42
62. N. Drakoulis I. Cascorbi J. Brockmöller C.R. Gross I. Roots Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7mutation (4889 A to G), and a T to C mutation in the 3′-flanking region Clin. Investig. 72 1994 240 248
63. C.M. Dresler Gender differences in genetic susceptibility for lung cancer Lung Cancer 30 2000 153 160
64. S. Dual R. Tweedie A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis J. Am. Stat. Assoc. 95 2000 89 98
65. E.J. Duell A population-based, case–control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk J. Natl. Cancer Inst. 94 2002 297 306
66. E.J. Duell E.A. Holly P.M. Bracci J.K. Wiencke K.T. Kelsey A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma Cancer Res. 62 2002 4630 4636
67. M. Egger D.G. Smith M. Schneider C. Minder Bias in meta-analysis detected by a simple, graphical test Br. Med. J. 315 1997 629 634
68. E. Elovaara Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver Arch. Toxicol. 81 2007 169 182
69. M. Esteller A. García J.M. Martínez-Palones J. Xercavins J. Reventós Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci Br. J. Cancer 75 1997 1385 1388
70. C.H. Fan Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer Zhonghua Yu Fang Yi Xue Za Zhi 40 2006 13 17
71. J.D. Figueroa Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors Cancer Causes Control 19 2008 917 929
72. X. Fontana Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases Mutat. Res. 403 1998 45 53
73. E. Fritsche Detection of cytochrome P450 1B1 Bfr I polymorphism: genotype distribution in healthy German individuals and in patients with colorectal carcinoma Pharmacogenetics 9 1999 405 408
74. M.P. Gallegos-Arreola Distribution of CYP1A1*2A polymorphism in adult patients with acute lymphoblastic leukemia in a Mexican population Blood Cells Mol. Dis. 41 2008 91 94
75. J.P. Gao Y.D. Huang G.Z. Yang Y.Q. Yang Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer Zhonghua Nan Ke Xue 9 2003 32 35
76. M. Garcia-Closas K.T. Kelsey J.K. Wiencke X. Xu J.C. Wain D.C. Christiani A case–control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States) Cancer Causes Control 8 1997 544 553
77. G.J. Gattás Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer Head Neck 28 2006 819 826
78. A. González V. Ramírez P. Cuenca R. Sierra Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility Rev. Biol. Trop. 52 2004 591 600
79. M.T. Goodman Case–control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism Cancer Epidemiol. Biomarkers Prev. 10 2001 209 216
80. S. Gronau D. Koenig-Greger M. Jerg H. Riechelmann (a). Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otolaryngol Head Neck Surg. 128 2003 674 680
81. S. Gronau D. Koenig-Greger M. Jerg H. Riechelmann GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity Oral Dis. 9 2003 62 67
82. A. Gsur Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk Anticancer Res. 21 2001 2237 2242
83. Y. Gu S. Zhang B. Lai H. Wang X. Zhan Relationship between genetic polymorphism of metabolizing enzymes and lung cancer susceptibility Zhongguo Fei Ai Za Zhi 7 2004 112 117
84. Y.F. Gu Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility Zhonghua Yi Xue Za Zhi 87 2007 3064 3068
85. T.Y. Guan M. Li Y.Q. Na Polymorphism of metabolic gene and genetic susceptibility to prostate cancer Zhonghua Wai Ke Za Zhi 43 2005 1467 1470
86. F.P. Guengerich T. Shimada Activation of procarcinogens by human cytochrome P450 enzymes Mutat. Res. 400 1998 201 213
87. A.C. Guilhen Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility Clin. Cancer Res. 15 2009 406 412
88. L.F. Gulyaeva Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia Adv. Exp. Med. Biol. 617 2008 359 366
89. G. Gutman CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer Int. J. Gynecol. Cancer 19 2009 1300 1302
90. V. Harth Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair J. Toxicol. Environ. Health A 71 2008 887 897
91. L.A. Hefler Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women Cancer 101 2004 264 269
92. J.P. Higgins S.G. Thompson J.J. Deeks D.G. Altman Measuring inconsistency in meta-analysis Br. Med. J. 327 2003 557 560
93. H. Hirata CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility Cancer 112 2008 1964 1973
94. A. Hirvonen Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer Pharmacogenetics 2 1992 259 263
95. A. Hirvonen K. Husgafvel-Pursiainen A. Karjalainen S. Anttila H. Vainio Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population Cancer Epidemiol. Biomarkers Prev. 1 1992 485 489
96. A. Hirvonen K. Husgafvel-Pursiainen S. Anttila A. Karjalainen H. Vainio Polymorphism in CYP1A1 and CYP2D6 genes: possible association with susceptibility to lung cancer Environ. Health Perspect. 101 1993 109 112
97. S.K. Holt Ovarian cancer risk and polymorphisms involved in estrogen catabolism Cancer Epidemiol. Biomarkers Prev. 16 2007 481 489
98. Y.S. Hong J.H. Chang O.J. Kwon Y.A. Ham J.H. Choi Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients Exp. Mol. Med. 30 1998 192 198
99. H.N. Honma Polymorphism of the CYP1A1*2A gene and susceptibility to lung cancer in a Brazilian population J. Bras. Pneumol. 35 2009 767 772
100. H. Hori T. Kawano M. Endo Y. Yuasa Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility J. Clin. Gastroenterol. 25 1997 568 575
101. S. Houlle Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers Eur. J. Hum. Genet. 19 2011 887 892
102. Y. Hu Q. Zhang Genetic polymorphisms of CYP1A1 and susceptibility of lung cancer Zhonghua Yi Xue Yi Chuan Xue Za Zhi 16 1999 26 28
103. C.S. Huang Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility Cancer Res. 59 1999 4870 4875
104. C.S. Huang C.Y. Shen K.J. Chang S.M. Hsu H.D. Chern Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan Br. J. Cancer 80 1999 1838 1843
105. Huang CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from Central South China Med. Oncol. 30 2013 521
106. A. Huber Ten polymorphisms of estrogen-metabolizing genes and a family history of colon cancer — an association study of multiple gene–gene interactions J. Soc. Gynecol. Investig. 12 2005 e51 e54
107. R. Ihsan Multiple analytical approaches reveal distinct gene–environment interactions in smokers and non smokers in lung cancer PLoS One 6 2011 e29431
108. T. Imaizumi Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population Carcinogenesis 30 2009 1729 1734
109. H. Inoue Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas Cancer Res. 60 2000 3749 3752
110. N. Ishibe Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans Cancer Epidemiol. Biomarkers Prev. 6 1997 1075 1080
111. N. Ishibe Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study Cancer Res. 58 1998 667 671
112. N. Ishibe M. Stampfer D.J. Hunter C. Hennekens K.T. Kelsey A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men Cancer Epidemiol. Biomarkers Prev. 9 2000 855 856
113. M.S. Islam Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population Clin. Chim. Acta 416 2013 11 19 10.1016/j.cca.2012.11.011 (Feb 1)
114. M. Jacquet Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence Eur. J. Cancer 32 1996 1701 1706
115. M. Jain S. Kumar U.C. Ghoshal B. Mittal CYP1A1 Msp1 T/C polymorphism in esophageal cancer: no association and risk modulation Oncol. Res. 16 2007 437 443
116. Y.N. Ji Q. Wang X.Q. Lin L.J. Suo CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects Cytokine 59 2012 324 334
117. Y. Jin Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case–control study in China BMC Cancer 10 2010 422
118. T. Joseph P. Kusumakumary P. Chacko A. Abraham M. Radhakrishna Pillai Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children Pediatr. Blood Cancer 43 2004 560 567
119. T. Joseph Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection Gynecol. Oncol. 101 2006 411 417
120. T. Juárez-Cedillo The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism Eur. J. Cancer 43 2007 1590 1595
121. C. Justenhoven Breast cancer: a candidate gene approach across the estrogen metabolic pathway Breast Cancer Res. Treat. 108 2008 137 149
122. S.Y. Kao Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use J. Oral Pathol. Med. 31 2002 505 511
123. I. Kato M. Cichon C.L. Yee S. Land J.F. Korczak African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer Cancer Epidemiol. 33 2009 24 30
124. K. Kawajiri Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene FEBS Lett. 263 1990 131 133
125. K.T. Kelsey J.K. Wiencke M.R. Spitz A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans Carcinogenesis 15 1994 1121 1124
126. I. Kerridge Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk Br. J. Haematol. 118 2002 477 481
127. E.P. Khvostova V.O. Pustylnyak L.F. Gulyaeva Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer Genet. Test. Mol. Biomarkers. 16 2012 167 173
128. M. Kihara M. Kihara K. Noda Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population Carcinogenesis 16 1995 2331 2336
129. J.W. Kim Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma Cancer 88 2000 2082 2091
130. H.N. Kim Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma Am. J. Hematol. 84 2009 821 825
131. H.N. Kim Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status Leuk. Lymphoma 53 2012 681 687
132. A. Kimura Effect of genetic predisposition on the risk of gallbladder cancer in Hungary Asian Pac. J. Cancer Prev. 9 2008 391 396
133. P.V. Kiruthiga M.R. Kannan C. Saraswathi S.K. Pandian K.P. Devi CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India Asian Pac. J. Cancer Prev. 12 2011 2133 2138
134. C. Kiyohara Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case–control study in Japanese nonsmoking women Int. J. Cancer 107 2003 139 144
135. C. Kiyohara T. Horiuchi K. Takayama Y. Nakanishi Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population J. Thorac. Oncol. 7 2012 954 962
136. J. Klinchid Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women Cancer Genet. Cytogenet. 195 2009 143 149
137. S.J. Klug TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies Lancet Oncol. 10 2009 772 784
138. Y. Ko Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue Cancer Res. 61 2001 4398 4404
139. M. Krajinovic D. Labuda C. Richer S. Karimi D. Sinnett Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms Blood 93 1999 1496 1501
140. M. Krajinovic Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene–environment interactions Int. J. Cancer 92 2001 220 225
141. W. Kristiansen CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility Int. J. Androl. 34 2011 77 83
142. V. Kumar CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer Chemosphere 81 2010 464 468
143. F. Laden Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study Cancer Epidemiol. Biomarkers Prev. 11 2002 1560 1565
144. S. Landi A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer Pharmacogenet. Genomics 15 2005 535 546
145. L. Le Marchand Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens Cancer Res. 58 1998 4858 4863
146. L. Le Marchand T. Donlon L.N. Kolonel B.E. Henderson L.R. Wilkens Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study Cancer Epidemiol. Biomarkers Prev. 14 2005 1998 2003
147. H.C. Lee Y.B. Yoon C.Y. Kim Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer Korean J. Intern. Med. 12 1997 128 136
148. K. Lee Allelic variants of cytochrome P4501A1 (CYP1A1), glutathione S transferase M1 (GSTM1) polymorphisms and their association with smoking and alcohol consumption as gastric cancer susceptibility biomarkers Rev. Med. Chil. 134 2006 1107 1115
149. K.M. Lee CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations Cancer Epidemiol. Biomarkers Prev. 17 2008 1120 1126
150. K.M. Lee Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk Leuk. Res. 33 2009 250 258
151. D. Lei Genetic polymorphism of cytochrome P4501A1 and susceptibility to laryngeal carcinoma Zhonghua Er Bi Yan Hou Ke Za Zhi 37 2002 373 376
152. D. Li DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer Mutat. Res. 513 2002 37 48
153. W.Y. Li B.T. Lai X.P. Zhan The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer Zhonghua Liu Xing Bing Xue Za Zhi 25 12 2004 1042 1045
154. Y. Li Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women Breast Cancer Res. 6 2004 R460 R473
155. Y. Li Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case–control study Breast Cancer Res. 7 2005 R12 R18
156. J.Y. Li Using MSR model to analyze the impact of gene–gene interaction with related to the genetic polymorphism of metabolism enzymes on the risk of breast cancer Sichuan Da Xue Xue Bao Yi Xue Ban 39 780–3 2008 787
157. M. Li T.Y. Guan Y. Li Y.Q. Na Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men Chin. Med. J. (Engl.) 121 2008 305 308
158. G.Y. Liang Y.P. Pu L.H. Yin Chuan Yi Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China 26 2004 584 588
159. M.M. Lima Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients Folia Biol. (Praha) 54 2008 102 108
160. P. Lin Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma Br. J. Cancer 82 2000 852 857
161. M.G. Lira Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients Exp. Dermatol. 15 2006 958 965
162. J. Little Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case–control study in the Grampian region of Scotland Int. J. Cancer 119 2006 2155 2164
163. Q.X. Liu Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province Zhonghua Liu Xing Bing Xue Za Zhi 26 2005 975 979
164. S.J. London Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism Cancer Res. 55 1995 6035 6037
165. R. Losi-Guembarovski Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population Anticancer Res. 28 2008 1023 1028
166. G.J. Lourenço E.F. Silva J.A. Rinck-Junior C.T. Chone C.S. Lima CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma Tumour Biol. 32 2011 1209 1215
167. D. Lucas Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians Alcohol. Clin. Exp. Res. 20 1996 1033 1037
168. Y.P. Luo Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility Tumour Biol. 32 2011 215 222
169. J.X. Ma Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China Cancer Lett. 240 2006 253 260
170. S. Majumdar Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia Eur. J. Cancer Prev. 17 2008 125 132
171. M.A. Malik Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley J. Gastrointest. Cancer 40 2009 26 32
172. M.A. Malik R. Upadhyay R.D. Mittal S.A. Zargar B. Mittal Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors Nutr. Cancer 62 2010 734 742
173. N. Mantel W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease Natl. Cancer Inst. 22 1959 719 748
174. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women Breast Cancer Res. Treat. 119 2010 463 474
175. C. Matthias Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers Pharmacogenetics 8 1998 91 100
176. C. Matthias V. Jahnke A.A. Fryer R.C. Strange First results on the influence of polymorphisms at glutathione S-transferase, cytochrome P450, and tumor necrosis factor gene loci on the development of multiple head and neck cancer Laryngorhinootologie 82 2003 25 30
177. M. McGrath S.E. Hankinson I. De Vivo Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States) Cancer Causes Control 18 2007 1123 1130
178. M.E. McManus Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450 Cancer Res. 50 1990 3367 3376
179. O.N. Mikhailova L.F. Gulyaeva A.V. Prudnikov A.V. Gerasimov S.E. Krasilnikov Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk Pharmacogenomics J. 6 2006 189 193
180. R.D. Mittal D.L. Srivastava Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene–environment interaction and risk of prostate cancer DNA Cell Biol. 26 2007 791 798
181. Y. Miyoshi Y. Takahashi C. Egawa S. Noguchi Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women Breast J. 8 2002 209 215
182. Y. Miyoshi Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk Eur. J. Cancer 39 2003 2531 2537
183. M. Moreno-Galván Impact of CYP1A1 and COMT genotypes on breast cancer risk in Mexican women: a pilot study Int. J. Biol. Markers 25 2010 157 163
184. P. Mota CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer Rev. Port. Pneumol. 16 2010 89 98
185. M. Murata Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan Jpn. J. Clin. Oncol. 28 1998 657 660
186. K. Nakachi S. Hayashi K. Kawajiri K. Imai Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation Carcinogenesis 16 1995 2209 2213
187. S.M. Naushad Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancer Cell Biochem. Biophys. 61 2011 715 723
188. D.W. Nebert T.P. Dalton The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis Nat. Rev. Cancer 6 2006 947 960
189. D.P. Ng K.W. Tan B. Zhao A. Seow CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation Cancer Causes Control 16 2005 399 405
190. H. Nisa Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study BMC Cancer 10 2010 274
191. K. Nishino Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer J. Obstet. Gynaecol. Res. 34 2008 994 1001
192. M. Ociepa-Zawal B. Rubiś V. Filas J. Breborowicz W.H. Trzeciak Studies on CYP1A1, CYP1B1 and CYP3A4 gene polymorphisms in breast cancer patients Ginekol. Pol. 80 2009 819 823
193. M. Okobia Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women Breast Cancer Res. Treat. 94 2005 285 293
194. Y. Osawa NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status Asian Pac. J. Cancer Prev. 8 2007 103 108
195. M.B. Oude Ophuis E.M. van Lieshout H.M. Roelofs W.H. Peters J.J. Manni Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions Cancer 82 1998 936 943
196. S.N. Pandey G. Choudhuri B. Mittal Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population Eur. J. Cancer Prev. 17 2008 77 81
197. I. Persson Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients Int. J. Cancer 81 1999 325 329
198. P. Pisani GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand Cancer Epidemiol. Biomarkers Prev. 15 2006 667 674
199. K. Pliarchopoulou Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers Oncol. Lett. 3 2012 1301 1306
200. L. Quiñones L. Gil Induction of rat hepatic cytochrome P450 1A1 isozyme by organic extracts from airborne particulate matter Xenobiotica 25 1995 571 579
201. L. Quiñones CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people Cancer Lett. 174 2001 35 44
202. L.A. Quiñones Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype–environment interaction study Asian J. Androl. 8 2006 349 355
203. X. R Yang R.M. Pfeiffer A.M. Goldstein Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome J. Med. Genet. 43 2006 e16
204. S. Raimondi Metabolic gene polymorphisms and lung cancer risk in non-smokers: an update of the GSEC study Mutat. Res. 592 2005 45 57
205. K.W. Reding Estrogen-related genes and their contribution to racial differences in breast cancer risk Cancer Causes Control 23 2012 671 681
206. M. Rojas Modulation of benzo[a] pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism Carcinogenesis 21 2000 35 41
207. R. Rosenthal The “file drawer problem” and tolerance for null results Psychol. Bull. 86 1979 638 641
208. M.J. Roth Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case–cohort study of cytochrome P-450 1A1 and GST enzymes Cancer Causes Control 15 2004 1077 1083
209. K. Sabitha M.V. Reddy K. Jamil Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer Cancer Epidemiol. 34 2010 587 592
210. C. Sachse A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer Carcinogenesis 23 2002 1839 1849
211. J. Sainz Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk Endocr. Relat. Cancer 18 2011 265 276
212. S.S. Sam V. Thomas S.K. Reddy G. Surianarayanan A. Chandrasekaran CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population Head Neck 30 2008 1566 1574
213. S.S. Sam V. Thomas K.S. Reddy G. Surianarayanan A. Chandrasekaran Gene–gene interactions of drug metabolizing enzymes and transporter protein in the risk of upper aerodigestive tract cancers among Indians Cancer Epidemiol. 34 2010 626 633
214. S.S. Sam V. Thomas K.S. Reddy G. Surianarayanan A. Chandrasekaran Gene–environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population J. Cancer Res. Clin. Oncol. 136 2010 945 951
215. S. Sangrajrang Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women Int. J. Cancer 125 2009 837 843
216. J. Sarmanová Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas Hum. Mol. Genet. 10 2001 1265 1273
217. M. Sato T. Sato T. Izumo T. Amagasa Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer Carcinogenesis 20 1999 1927 1931
218. J. Schneider U. Bernges CYP1A1 and CYP1B1 polymorphisms as modifying factors in patients with pneumoconiosis and occupationally related tumours: a pilot study Mol. Med. Rep. 2 2009 1023 1028
219. A. Seremak-Mrozikiewicz CYP1A1 alleles in female genital cancers in the Polish population Eur. J. Obstet. Gynecol. Reprod. Biol. 118 2005 246 250
220. T.N. Sergentanis K.P. Economopoulos S. Choussein N.F. Vlahos Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis Mol. Biol. Rep. 39 2012 9921 9930
221. S.M. Shaffi CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population Asian Pac. J. Cancer Prev. 10 2009 651 656
222. P.P. Shah Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer Mutat. Res. 639 2008 1 10
223. P.P. Shah K. Saurabh M.C. Pant N. Mathur D. Parmar Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients Mutat. Res. 670 2009 74 78
224. R. Sharma M. Ahuja N.K. Panda M. Khullar Combined effect of smoking and polymorphisms in tobacco carcinogen-metabolizing enzymes CYP1A1 and GSTM1 on the head and neck cancer risk in north Indians DNA Cell Biol. 29 2010 441 448
225. Y. Shen D.K. Li J. Wu Z. Zhang E. Gao Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case–control study in Shanghai, China Cancer Epidemiol. Biomarkers Prev. 15 2006 342 347
226. P.G. Shields Lung cancer, race, and a CYP1A1 genetic polymorphism Cancer Epidemiol. Biomarkers Prev. 2 1993 481 485
227. T. Shimada Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons Drug Metab. Pharmacokinet. 21 2006 257 276
228. N. Shimada Genetic polymorphisms in estrogen metabolism and breast cancer risk in case–control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians J. Hum. Genet. 54 2009 209 215
229. A. Shin Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women Exp. Mol. Med. 39 2007 361 366
230. D. Shukla A. Dinesh Kale S. Hallikerimath S. Vivekanandhan Y. Venkatakanthaiah Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 156 2012 253 259
231. Y. Silig Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population Cancer Invest. 24 2006 41 45
232. L. Silvestri CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer Int. J. Cancer 104 2003 310 317
233. N. Singh Association of CYP1A1 polymorphisms with breast cancer in north Indian women Oncol. Res. 16 2007 587 597
234. V. Singh A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women Breast Cancer Res. Treat. 101 2007 73 81
235. A.P. Singh Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk Cancer Invest. 27 2009 869 876
236. R. Singh Gene polymorphisms, tobacco exposure and oral cancer susceptibility: a study from Gujarat, West India Oral Dis 2013 10.1111/odi.12079
237. A.K. Siraj Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population BMC Med. Genet. 9 2008 61
238. L. Sivaraman CYP1A1 genetic polymorphisms and in situ colorectal cancer Cancer Res. 54 1994 3692 3695
239. M.L. Slattery CYP1A1, cigarette smoking, and colon and rectal cancer Am. J. Epidemiol. 160 2004 842 852
240. R.C. Sobti S. Sharma A. Joshi S.K. Jindal A. Janmeja CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a north Indian population Biomarkers 8 2003 415 428
241. R.C. Sobti S. Sharma A. Joshi S.K. Jindal A. Janmeja Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population Mol. Cell. Biochem. 266 2004 1 9
242. N. Song W. Tan D. Xing D. Lin CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case–control study in China Carcinogenesis 22 2001 11 16
243. Y. Souiden M. Mahdouani K. Chaieb A. Bakhrouf K. Mahdouani Lack of association of CYP1A1 polymorphism with prostate cancer susceptibility of Tunisian men Genet. Test. Mol. Biomarkers 16 2012 661 666
244. D.C. Spink 17 Beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetra-chlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA Arch. Biochem. Biophys. 293 1992 342 348
245. L. Sreeja Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a south Indian population J. Hum. Genet. 50 2005 618 627
246. D.S. Srivastava A. Mandhani R.D. Mittal Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from north India Arch. Toxicol. 82 2008 633 669
247. T. Sugawara E. Nomura T. Sagawa N. Sakuragi S. Fujimoto CYP1A1 polymorphism and risk of gynecological malignancy in Japan Int. J. Gynecol. Cancer 13 2003 785 790
248. H. Sugimura CYP1A1 and CYP2E1 polymorphism and lung cancer, case–control study in Rio de Janeiro, Brazil Pharmacogenetics 5 1995 S145 S148
249. K.J. Suneetha Role of glutathione-S-transferase and CYP1A1*2A polymorphisms in the therapy outcome of south Indian acute lymphoblastic leukemia patients Indian J. Med. Paediatr. Oncol. 32 2011 25 29
250. K. Suzuki Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case–control study Cancer Lett. 195 2003 177 183
251. R.M. Swinney Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children Cancer Epidemiol. Biomarkers Prev. 20 2011 1537 1542
252. V.S. Syamala Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population Cancer Invest. 28 2010 304 311
253. J. Tai Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population Cancer Genet. Cytogenet. 196 2010 76 82
254. E. Taioli A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung Cancer Res. 55 1995 472 473
255. E. Taioli J. Trachman X. Chen P. Toniolo S.J. Garte A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women Cancer Res. 55 1995 3757 3758
256. E. Taioli Lung cancer risk and CYP1A1 genotype in African Americans Carcinogenesis 19 1998 813 817
257. E. Taioli Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk Cancer Detect. Prev. 23 1999 232 237
258. E. Taioli Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years Int. J. Epidemiol. 32 2003 60 63
259. K. Tanimoto S. Hayashi K. Yoshiga T. Ichikawa Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose Oral Oncol. 35 1999 191 196
260. T. Tefre Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population Pharmacogenetics 1 1991 20 25
261. K.L. Terry L. Titus-Ernstoff E.O. Garner A.F. Vitonis D.W. Cramer Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk Cancer Epidemiol. Biomarkers Prev. 12 2003 187 190
262. C. Torresan Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes Clin. Exp. Med. 8 2008 65 71
263. Y. Tsuchiya Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer J. Exp. Clin. Cancer Res. 21 2002 119 124
264. Y. Tsuchiya Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women Int. J. Biol. Markers 25 2010 75 78
265. M. Tuerxun W. Hamulati L. Bai X.M. Peng M. Dolikun Study of cytochrome P450 1A1 gene 3′-UTR 6235T-C polymorphism and susceptibility to breast cancer with Uighur medicine Zhonghua Yi Xue Za Zhi 91 2011 86 91
266. E.M. van Lieshout Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma Cancer Res. 59 1999 586 589
267. G. Varzim E. Monteiro R.A. Silva J. Fernandes C. Lopes CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx Eur. J. Cancer Prev. 12 2003 495 499
268. K. Vijayalakshmi Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer Cancer Biomark. 1 2005 251 258
269. H. von Keyserling Analysis of 4 single-nucleotide polymorphisms in relation to cervical dysplasia and cancer development using a high-throughput ligation-detection reaction procedure Int. J. Gynecol. Cancer 21 2011 1664 1671
270. J. Wang Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case–control study in Chinese population Cancer Sci. 94 2003 448 452
271. L.D. Wang CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high-incidence area in north China World J. Gastroenterol. 9 2003 1394 1397
272. B.G. Wang A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer Zhonghua Zhong Liu Za Zhi 26 2004 93 97
273. D. Wang S. Chen B. Wang W. Zhou A case–control study on the impact of cytochrome P450 2E1 and 1A1 gene polymorphisms on the risk of lung cancer of the Han nationality in Guangzhou district Zhongguo Fei Ai Za Zhi 9 2006 497 501
274. G. Wang Risk factor for clear cell renal cell carcinoma in Chinese population: a case–control study Cancer Epidemiol. 36 2012 177 182
275. N. Wang Y. Wu X. Zhou Y. Wu Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population Wei Sheng Yan Jiu 41 2012 251 256
276. A.S. Wenzlaff CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study Carcinogenesis 26 2005 2207 2212
277. M.R. Wrensch CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans Int. J. Cancer 113 2005 141 147
278. C.M. Wright Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer Eur. Respir. J. 35 2010 152 159
279. F.Y. Wu Y.J. Lee D.R. Chen H.W. Kuo Association of DNA–protein crosslinks and breast cancer Mutat. Res. 501 2002 69 78
280. M.T. Wu Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan Br. J. Cancer 87 2002 529 532
281. X. Xu K.T. Kelsey J.K. Wiencke J.C. Wain D.C. Christiani Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility Cancer Epidemiol. Biomarkers Prev. 5 1996 687 692
282. G.G. Yamaguti G.J. Lourenço F.F. Costa C.S. Lima High risk of ‘de novo’ acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects Eur. J. Haematol. 83 2009 270 272
283. G.G. Yamaguti Increased risk for acute lymphoblastic leukemia in children with cytochrome P450A1 (CYP1A1)- and NAD(P)H:quinine oxidoreductase 1 (NQO1)-inherited gene varian'ts Acta Haematol. 124 2010 182 184
284. J. Yang Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case–control study in a Han nationality population in Southern China Int. J. Urol. 13 2006 773 780
285. Z. Ye J.M. Parry Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer Teratog. Carcinog. Mutagen. 22 2002 385 392
286. L. Yengi Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma Cancer Res. 56 1996 1974 1977
287. L. Yin Genetic polymorphisms of NAD(P)H quinine oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China Lung Cancer 33 2001 133 141
288. P.H. Yin Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females Cancer Lett. 212 2004 195 201
289. K. Yoshida Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking Asian Pac. J. Cancer Prev. 8 2007 438 444
290. M.W. Yu A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers Hepatology 29 1999 697 702
291. M.W. Yu Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers Br. J. Cancer 80 1999 598 603
292. X. Yuan Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma Cancer Epidemiol. Biomarkers Prev. 17 2008 3621 3627
293. Y. Zhang Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women Am. J. Epidemiol. 160 2004 1177 1183
294. S.F. Zhou J.P. Liu B. Chowbay Polymorphism of human cytochrome P450 enzymes and its clinical impact Drug Metab. Rev. 41 2009 89 95
295. J. Zhu Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer Cancer Epidemiol. Biomarkers Prev. 12 2003 830 837
296. W. Zhuo L. Zhang Z. Qiu B. Zhu Z. Chen Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Gene 510 2012 14 21
297. X. Zhuo Quantitative assessment of CYP1A1*2A variations with oral carcinoma susceptibility: evidence from 1438 cases and 2086 controls Cancer Invest. 30 2012 552 559
298. S. Zienolddiny A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers Carcinogenesis 29 2008 1164 1169